FASTK
Fas-activated serine/threonine kinase
Also known as: FAST, FASTK_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14296
- Gene
- FASTK
- Ensembl
- ENSG00000164896
- Chromosome
- 7
- Canonical length
- 549 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nuclear speckles,Mitochondria
OverviewNCBI Gene
The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase was shown to be activated rapidly during Fas-mediated apoptosis in Jurkat cells. In response to Fas receptor ligation, it phosphorylates TIA1, an apoptosis-promoting nuclear RNA-binding protein. The encoded protein is a strong inducer of lymphocyte apoptosis. Two transcript variants encoding different isoforms have been found for this gene. Other variants exist, but their full-length natures have not yet been determined. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
549 residues, UniProt reviewed canonical sequence.
>Q14296|FASTK
1 MRRPRGEPGP RAPRPTEGAT CAGPGESWSP SPNSMLRVLL SAQTSPARLS GLLLIPPVQP
61 CCLGPSKWGD RPVGGGPSAG PVQGLQRLLE QAKSPGELLR WLGQNPSKVR AHHYSVALRR
121 LGQLLGSRPR PPPVEQVTLQ DLSQLIIRNC PSFDIHTIHV CLHLAVLLGF PSDGPLVCAL
181 EQERRLRLPP KPPPPLQPLL RGGQGLEAAL SCPRFLRYPR QHLISSLAEA RPEELTPHVM
241 VLLAQHLARH RLREPQLLEA IAHFLVVQET QLSSKVVQKL VLPFGRLNYL PLEQQFMPCL
301 ERILAREAGV APLATVNILM SLCQLRCLPF RALHFVFSPG FINYISGTPH ALIVRRYLSL
361 LDTAVELELP GYRGPRLPRR QQVPIFPQPL ITDRARCKYS HKDIVAEGLR QLLGEEKYRQ
421 DLTVPPGYCT DFLLCASSSG AVLPVRTQDP FLPYPPRSCP QGQAASSATT RDPAQRVVLV
481 LRERWHFCRD GRVLLGSRAL RERHLGLMGY QLLPLPFEEL ESQRGLPQLK SYLRQKLQAL
541 GLRWGPEGGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FASTK can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 115 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 115 nTPM
- tongue: 89 nTPM
- heart muscle: 65 nTPM
- liver: 58 nTPM
- kidney: 44 nTPM
- cerebral cortex: 43 nTPM
Single-cell type
- esophageal suprabasal cells: 113 nCPM
- esophageal apical cells: 94 nCPM
- early primary spermatocytes: 90 nCPM
- esophageal basal cells: 88 nCPM
- melanocytes: 85 nCPM
- enterocytes: 75 nCPM
Immune cell
- plasmacytoid DC: 38 nTPM
- non-classical monocyte: 33 nTPM
- intermediate monocyte: 32 nTPM
- classical monocyte: 31 nTPM
- eosinophil: 30 nTPM
- myeloid DC: 28 nTPM
Brain region
- thalamus: 25 nTPM
- amygdala: 24 nTPM
- cerebral cortex: 24 nTPM
- pons: 22 nTPM
- medulla oblongata: 22 nTPM
- hippocampal formation: 22 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.58
- gnomAD pLI
- 0
- gnomAD missense Z
- 2.11
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic signaling pathway
- mitochondrial RNA processing
- protein phosphorylation
- regulation of mitochondrial mRNA stability
- regulation of RNA splicing
Molecular functions
- ATP binding
- protein serine kinase activity
- protein serine/threonine kinase activity
- RNA binding
- Fas-activated serine/threonine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FASTK in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FASTK as an antibody target. Whether an autoantibody or antibody against FASTK could matter depends on whether native FASTK is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FASTK is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FASTK as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...